ID
34656
Description
Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01441973
Link
https://clinicaltrials.gov/show/NCT01441973
Keywords
Versions (1)
- 1/22/19 1/22/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 22, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Smoldering Multiple Myeloma NCT01441973
Eligibility Smoldering Multiple Myeloma NCT01441973
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Multiple Myeloma
Data type
boolean
Alias
- UMLS CUI [1]
- C0026764
Description
Monoclonal Gammopathy of Undetermined Significance
Data type
boolean
Alias
- UMLS CUI [1]
- C0026470
Description
Leukemia, Plasma Cell
Data type
boolean
Alias
- UMLS CUI [1]
- C0023484
Description
Hepatitis B positive | Hepatitis C positive | HIV Seropositivity
Data type
boolean
Alias
- UMLS CUI [1]
- C0856706
- UMLS CUI [2]
- C1112419
- UMLS CUI [3]
- C0019699
Similar models
Eligibility Smoldering Multiple Myeloma NCT01441973
- StudyEvent: Eligibility
C0242485 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0242485 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C2826181 (UMLS CUI [3])
C0042037 (UMLS CUI [1,2])
C2238293 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C3274398 (UMLS CUI [3])
C1112419 (UMLS CUI [2])
C0019699 (UMLS CUI [3])